Oxidant-mediated modification and cross-linking of beta-2-microglobulin
Abstract
Beta-2-microglobulin (B2M) is synthesized by all nucleated cells and forms part of the major histocompatibility complex (MHC) class-1 present on cell surfaces, which presents peptide fragments to cytotoxic CD8(+) T -lymphocytes, or by association with CD1, antigenic lipids to natural killer T-cells. Knockout of B2M results in loss of these functions and severe combined immunodeficiency. Plasma levels of this protein are low in healthy serum, but are elevated up to 50-fold in some pathologies including chronic kidney disease and multiple myeloma, where it has both diagnostic and prognostic value. High levels of the protein are associated with amyloid formation, with such deposits containing significant levels of modified or truncated protein. In the current study we examine the chemical and structural changes induced of B2M generated by both inflammatory oxidants (HOCl and ONOOH), and photo-oxidation (O-1(2)) which is linked with immunosuppression. Oxidation results in oligomer formation, with this occurring most readily with HOCl and O-1(2), and a loss of native protein conformation. LC-MS analysis provided evidence for nitrated (from ONOOH), chlorinated (from HOCl) and oxidized residues (all oxidants) with damage detected at Tyr, Trp, and Met residues, together with cleavage of the disulfide (cystine) bond. An intermolecular di-tyrosine crosslink is also formed between Tyr10 and Tyr63. The pattern of these modifications is oxidant specific, with ONOOH inducing a greater range of modifications than HOCl. Comparison of the sites of modification with regions identified as amyloidogenic indicate significant co-localization, consistent with the hypothesis that oxidation may contribute, and predispose B2M, to amyloid formation.
Más información
Título según WOS: | ID WOS:000808015100006 Not found in local WOS DB |
Título de la Revista: | FREE RADICAL BIOLOGY AND MEDICINE |
Volumen: | 187 |
Editorial: | Elsevier Science Inc. |
Fecha de publicación: | 2022 |
Página de inicio: | 59 |
Página final: | 71 |
DOI: |
10.1016/j.freeradbiomed.2022.05.012 |
Notas: | ISI |